These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Clinical and electrophysiological characteristics of vascular rejection after cardiac transplantation. Weyand M; Konertz W; Fahrenkamp A; Torp U; Bernhard A; Scheld HH Transplant Proc; 1992 Oct; 24(5):2009-10. PubMed ID: 1412951 [No Abstract] [Full Text] [Related]
17. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Marin-Neto JA; Rassi A; Morillo CA; Avezum A; Connolly SJ; Sosa-Estani S; Rosas F; Yusuf S; Am Heart J; 2008 Jul; 156(1):37-43. PubMed ID: 18585495 [TBL] [Abstract][Full Text] [Related]
18. A 23 years of uneventful evolution in a heart-transplanted patient with chagasic cardiomyopathy on a two-drug immunosuppressive protocol. Andrade Vila JH; Zerbini E; Bitencourt D; Carvalho V; Macruz R; Da Silva JP; Baumgratz JF; Da Fonseca L; De Souza M; D'Andretta Neto C Transplantation; 2009 Feb; 87(3):454-5. PubMed ID: 19202456 [No Abstract] [Full Text] [Related]